- Home
- NVNO vs GRDX Comparison
NVNO vs GRDX Comparison
Compare NVNO & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVNO | GRDX |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 8.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVNO | GRDX |
|---|---|---|
| Price | $11.93 | $3.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.7K | ★ 155.2K |
| Earning Date | 02-27-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.42 | $1.92 |
| 52 Week High | $196.70 | $5.30 |
Technical Indicators
Market Signals| Indicator | NVNO | GRDX |
|---|---|---|
| Relative Strength Index (RSI) | 82.69 | 47.32 |
| Support Level | $9.98 | $2.67 |
| Resistance Level | $11.40 | $3.39 |
| Average True Range (ATR) | 1.05 | 0.42 |
| MACD | 0.67 | -0.15 |
| Stochastic Oscillator | 93.05 | 28.76 |
Price Performance
Historical ComparisonAbout NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.